Drug profile · INN
flecainide
FLECAINIDE SANDOZ
flecainide (FLECAINIDE SANDOZ) is a sodium channel protein type v alpha subunit blocker. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — flecainide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.81
Quick answer
flecainide (FLECAINIDE SANDOZ) is a sodium channel protein type v alpha subunit blocker. Associated with Alphapharm Pty Ltd.
Key facts
INN flecainide
Brand FLECAINIDE SANDOZ
Mechanism Sodium channel protein type V alpha subunit blocker
Originator Alphapharm Pty Ltd
Mechanism of action
Sodium channel protein type V alpha subunit blocker
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is flecainide?
flecainide (FLECAINIDE SANDOZ) is a sodium channel protein type v alpha subunit blocker. Associated with Alphapharm Pty Ltd.
What is the brand name for flecainide?
FLECAINIDE SANDOZ is a marketed brand name for flecainide. Check FDA Drugs@FDA for the current US label holder and prescribing information.